Celimmune Founded to Develop Novel Therapeutics for Celiac Disease (and Other Autoimmune Diseases)

LEBANON, N.J. and BETHESDA, Md., Feb. 23, 2015 /PRNewswire/ — Celimmune LLC, a clinical development-stage immunotherapy company targeting autoimmunity and inflammation, today announced that it will initially focus its distinctive core competence in translational medicine, immunotherapy clinical development and commercialization on combating celiac disease. Read more HERE



Related Posts Plugin for WordPress, Blogger...

On February 27th, 2015, posted in: CeliacCorner Blogs by

Leave a comment - awaits moderation

Your email address will not be published. Required fields are marked *